Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Toxicity in Neurodegeneration
Shuyu Liang, Zuo-Teng Wang, Lan Tan, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3617-3634
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
Andrea Corsi, Cristina Bombieri, Maria Teresa Valenti, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15383-15383
Open Access | Times Cited: 48
Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
Antonis Roussos, Katerina Kitopoulou, Fivos Borbolis, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 478-478
Open Access | Times Cited: 30
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Huiting Zheng, Huimin Sun, Qixu Cai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4969-4969
Open Access | Times Cited: 12
The Link Between Matrix Metalloproteinases and Alzheimer’s Disease Pathophysiology
Dominika Radošinská, Jana Radošinská
Molecular Neurobiology (2024)
Open Access | Times Cited: 10
A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory
Zhihan Chen, Xinrui Wang, Simin Du, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Assessment of Efficacy and Safety of Zagotenemab
Adam Fleisher, Leanne Munsie, David Pérahia, et al.
Neurology (2024) Vol. 102, Iss. 5
Open Access | Times Cited: 7
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
Subha Kalyaanamoorthy, Stanley Opare, Xiaoxiao Xu, et al.
Current Alzheimer Research (2024) Vol. 21, Iss. 1, pp. 24-49
Closed Access | Times Cited: 6
Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Tau Aggregation‐Dependent Lipid Peroxide Accumulation Driven by the hsa_circ_0001546/14‐3‐3/CAMK2D/Tau Complex Inhibits Epithelial Ovarian Cancer Peritoneal Metastasis
Binshu Chai, Yong Wu, HengHui Yang, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 5
The coherence between PSMC6 and α-ring in the 26S proteasome is associated with Alzheimer’s disease
Jing Xiong, Xinping Pang, Xianghu Song, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Mouse serum albumin induces neuronal apoptosis and tauopathies
Shengjie Hou, Yaru Huang, Jie Zhu, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Qiu Jiang, Jie Liu, Shan Huang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Infections, Genetics, and Alzheimer's Disease: Exploring the Pathogenic Factors for Innovative Therapies
Ramesh Kordi, T. John Andrews, Mark D. Hicar
Virology (2025), pp. 110523-110523
Closed Access
Heterogeneous Tau Oligomers as Molecular Targets for Alzheimer’s Disease and Related Tauopathies
Chih Hung Lo
Biophysica (2022) Vol. 2, Iss. 4, pp. 440-451
Open Access | Times Cited: 16
Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease
Milad Noori, Navid Dastyafteh, Sajedeh Safapoor, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127392-127392
Closed Access | Times Cited: 10
Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis
Zaida L. Almeida, Daniela C. Vaz, Rui M. M. Brito
Molecular Neurobiology (2024)
Open Access | Times Cited: 3
Applications and challenges of rhodopsin-based optogenetics in biomedicine
Hanci Zhang, Hui Fang, Deqiang Liu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 14
Orexin-A aggravates cognitive deficits in 3xTg-AD mice by exacerbating synaptic plasticity impairment and affecting amyloid β metabolism
Yiying Li, Kai-Yue Yu, Yujia Cui, et al.
Neurobiology of Aging (2023) Vol. 124, pp. 71-84
Closed Access | Times Cited: 8
Rottlerin Enhances the Autophagic Degradation of Phosphorylated Tau in Neuronal Cells
Min Kyoung Kam, Jee-Yun Park, Gwang Ho Yun, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9633-9645
Closed Access | Times Cited: 2
Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer’s disease
Klara Gawor, Sandra O. Tomé, Rik Vandenberghe, et al.
Brain Communications (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 2
Tubulin Cytoskeleton in Neurodegenerative Diseases–not Only Primary Tubulinopathies
Zuzanna Cyske, Lidia Gaffke, Karolina Pierzynowska, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 5, pp. 1867-1884
Open Access | Times Cited: 10
The long non-coding RNA BDNF-AS induces neuronal cell apoptosis by targeting miR-125b-5p in Alzheimer’s disease models
Haiyan Ren, Weibin Qiu, Benju Zhu, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 33, Iss. 3, pp. 233-245
Open Access | Times Cited: 6
Selective orexin 1 receptor antagonist SB-334867 aggravated cognitive dysfunction in 3xTg-AD mice
Wen-Rui Gao, Xiaohong Hu, Kai-Yue Yu, et al.
Behavioural Brain Research (2022) Vol. 438, pp. 114171-114171
Closed Access | Times Cited: 9
A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies
Joana Ribeiro, Ivo Lopes, Andreia C. Gomes
Molecules (2023) Vol. 28, Iss. 16, pp. 6015-6015
Open Access | Times Cited: 5
Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications
Md. Ataur Rahman, MD. Hasanur Rahman, Hyewhon Rhim, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 12, pp. 1942-1959
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top